Clinical trials: Treatment Of Obesity
Obesity/Overweight
Efficacy and Safety of ALT-801 in the Treatment of Obesity
This study will evaluate the efficacy and safety of ALT-801 once-weekly versus placebo as an adjunct to a reduced-calorie diet and increased physical activity in patients with obesity/overweight.
- Trial name
- NCT05295875
- Testing
- ALT-801
- Where
- 31 sites in United States
- Volunteers
- 391 people
- Sponsor
- Altimmune, Inc.
Obese Patients (BMI ≥ 30 kg/m²), Anxiety
Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.
Obese individuals are a particularly vulnerable population for mental health problems, especially depression and anxiety. The aim of this study is to evaluate whether the intake of a synbiotic, composed of prebiotics and…
- Conditions
- Obese Patients (BMI ≥ 30 kg/m²), Anxiety, Depressive Disorder
- Trial name
- NCT06901739
- Testing
- Synbiotic
- Where
- Spain
- Volunteers
- 120 people
- Sponsor
- Celia Bañuls
Obesity, Overweight
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
The purpose of this clinical study is to look at the safety of the medicine Cagrilintide when compared to placebo in people who do not tolerate marketed glucagon-like peptide-1 (GLP-1) therapies and who live with overweight or…
- Trial name
- NCT07607587
- Testing
- Cagrilintide
- Where
- 13 sites in United States
- Volunteers
- 114 people
- Sponsor
- Novo Nordisk A/S
Obesity
A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
The main purpose of this study is to evaluate the safety and tolerability of tirzepatide (LY3298176) in pediatric participants with obesity.
- Trial name
- NCT05696847
- Testing
- Tirzepatide
- Where
- 3 sites in United States
- Volunteers
- 28 people
- Sponsor
- Eli Lilly and Company
Weight Loss, Obese Children and Adolescents
The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children
The incidence of childhood obesity is increasing, followed by metabolic diseases related to overweight and obesity in children. High intensity interval training (HIIT) has recently been shown to improve the body composition and…
- Trial name
- NCT06205563
- Testing
- high-intensity interval training, moderate intensity continuous training
- Volunteers
- 388 people
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
Childhood Obesity, Minority Health
Family, Responsibility, Education, Support, and Health for Latino Caregivers (FRESH-LC)
The objective of this proposed study is to collect initial efficacy data on a telehealth family-based behavioral program for Latino children with overweight or obesity, which also includes additional caregiver support (PBT-AC)…
- Trial name
- FRESH-LC (NCT05437406)
- Testing
- Parent-based treatment- All caregivers (PBT-AC), Health Education (HE)
- Where
- United States
- Volunteers
- 167 people
- Sponsor
- University of California, San Diego
Metabolic Syndrome X
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
The Metabolic Syndrome is a high prevalence disease worldwide. About a quarter of the adult population suffers the disease. Resveratrol is a substance found in many plants, including grapes, nuts and wine, but it's also found in…
- Trial name
- NCT02114892
- Testing
- Resveratrol
- Where
- Mexico
- Volunteers
- 24 people
- Sponsor
- University of Guadalajara
Bulimia, Obesity
Treatment of Binge Eating Disorder
This is a multicenter (2 sites) randomized trial evaluating three group treatment models for subjects with binge eating disorder.
- Trial name
- NCT00039936
- Testing
- Cognitive Behavior Treatment, Self Help, Partial Self Help
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obesity
Prospective Multicenter Study With the Endomina® Triangulation Platform
This registry is designed to further assess on a larger scale safety and efficacy of the endomina® device and tissue apposition accessories (TAPES) when used in the frame of "real life" routine clinical practice
- Trial name
- PRETTi (NCT05677464)
- Where
- Belgium
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Endo Tools Therapeutics S.A.
Obesity
Effect of Shock Wave Therapy Without Biological and Immuno-histochemical Analysis.
Informative Summary: Extracorporeal shockwave therapy (ESWT) is a new method for treating aesthetic disorders within the field of aesthetic medicine, its mechanisms of action and physiological effects promise to combat localized…
- Trial name
- ESWT (NCT05017636)
- Testing
- shock wave therapy
- Where
- Brazil
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Indústria Brasileira Equipamentos Médicos - IBRAMED
Obesity, Overweight
A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
Phase 2 clinical study will evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of various aleniglipron (GSBR-1290) dose regimens compared with placebo in participants living with obesity or overweight with ≥ 1…
- Conditions
- Obesity, Overweight, Chronic Weight Management
- Trial name
- ACCESS II (NCT06703021)
- Where
- 10 sites in United States
- Volunteers
- 85 people
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Obesity
A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112
1. Study Objective <Part 1> To evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after multiple oral administration in healthy female subjects.
- Trial name
- NCT04703764
- Testing
- HSG4112
- Where
- 2 sites in South Korea
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Glaceum
Diabetes Mellitus
Physical Therapy for Diabetes Mellitus
Background: The aim of this study to compare the effect of moderate exercises versus light exercises on patients with type 2 diabetes mellitus.
- Trial name
- NCT04622371
- Testing
- Moderate exercises
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Cairo University
Obesity and Overweight, Overweight or Obese
Innovative Functional Product for Overweight and Obesity
The aim of this randomized, parallel, two-arm, placebo-controlled, quadruple-blind clinical trial is to evaluate the efficacy of a polyphenol-enriched functional product in individuals with overweight or obesity, focusing…
- Conditions
- Obesity and Overweight, Overweight or Obese, Overweight or Obese Adults, Obese Subjects
- Trial name
- NCT07044167
- Testing
- Polyphenol-enriched functional product, Control without active polyphenols
- Where
- Spain
- Volunteers
- 70 people
- Sponsor
- Carmen Lucas Abellán
Healthy Volunteer
Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes
A Multiple Dose, Randomized, Placebo-controlled, Dose-escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MD-18 for healthy subjects with overweight or obesity
- Trial name
- NCT06739707
- Testing
- MD-18
- Where
- Israel
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Cohen Global, Ltd.
Gout, Arthritis, Obesity
Weight Loss for Obese Individuals With Gout
This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in the form of meal replacement from…
- Trial name
- NCT03664167
- Testing
- intensive weight loss diet, with Cambridge weightplan products, and visits to a dietician.
- Where
- Denmark
- Volunteers
- 60 people
- Sponsor
- Henning Bliddal
Obesity
The ePass Clinical Trial for the Treatment of Obese Subjects
To evaluate the safety and efficacy of the endoscopically implanted ValenTx EndoPass™ System for treatment of adults with severe obesity.
- Trial name
- ePass (NCT02954016)
- Testing
- ePass
- Where
- 2 sites in Argentina, Mexico
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- ValenTx, Inc.
Fatty Liver, Nonalcoholic Steatohepatitis
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
This study will evaluate the effectiveness of pioglitazone, a new diabetes medicine, on decreasing insulin resistance and improving liver disease in patients with nonalcoholic steatohepatitis (NASH).
- Trial name
- NCT00013598
- Testing
- Pioglitazone
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obesity
Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety
CP-945,598 is eliminated primarily by enzyme CYP3A. Grapefruit juice may affect the activity of CYP3A and alter the amount of CP-945,598 in the blood.
- Trial name
- NCT00645216
- Testing
- CP-945,598
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Pfizer
Overweight and Obesity
A Group-based Treatment of Overweight and Obesity in Primary Care
Overweight and obesity is a growing problem in the world. Today more than 50 % of all people over 18 years in Sweden are overweight or obese.
- Trial name
- NCT03914066
- Testing
- A group-based treatment of overweight and obesity
- Where
- Sweden
- Volunteers
- 39 people
- Sponsor
- Region Örebro County
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.